Published :
Tables : 67
Figures : 50
Category : Healthcare
No. of Pages : 240
Report Code : HC-U3304
HLA Typing Market is projected to value over USD 1 billion by 2027 end with a CAGR of over 6.5% during the forecast period 2020 to 2027. Increased insistence for diagnostic products, increased private-public collaboration for extensive HLA research, rising prevalence of infectious diseases and soaring number of transplant processes are some of the crucial factors responsible for the growth of the market. HLA class I and II antigen identification is performed by the procedure of molecular diagnostics that is based on DNA. These novel innovations of the DNA are being utilised by the HLA typing that provide more accurate, vigorous results that rely on identifying the differences in HLA genes. Furthermore, advancements in technology, rise in the number of processes that involve stem cell transplantation, soft tissue transplantation and solid organ transplantation, bolstering support in R&D, escalating public and private funds are some of the other driving factors responsible for the HLA typing market growth. Additionally, the technological shift to gene-based HLA profiling from serological assays shall boost the proliferation of the market. Market Segmentation: By Technology • Molecular Assay Technologies • Non-Molecular Assay Technology By Products and Services • Reagents and Consumables • Instruments • Software and Services By Application • Diagnostic Applications • Research Applications By End User • Independent Reference Laboratories • Hospitals and Transplant Centers • Research Laboratories • Academic Institutes By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is fragmented into technology, products and services, application, end user and region. The technology segment is categorised into molecular assay technology and non-molecular assay technology. The molecular assay technology is divided into PCR-based molecular assays and sequencing based molecular assays. The molecular assay technology segment is predicted to hold the largest HLA typing market and this can be credited to the advantages provided by assays like high procedural efficacy, low turnaround time, real-time sample analysis and multi sample studying. The products and service segment is divided into reagents and consumables, instruments, software and services. The application segment is bifurcated into diagnostic applications and research applications. The end user segment is classified into hospitals and transplant centres, research laboratories, academic institutes and independent reference laboratories. The independent reference laboratories dominated the market, and this can be credited to the automation and rapid modernization of diagnostic labs, increased R&D activities that are outsourced by biotech and pharmaceutical companies. Regional Analysis: The North America region is expected to subjugate the market during the forecast period owing to advancements in the healthcare, increase in the number of organ transplantation surgeries performed and advancements in the transplant diagnostic technology. Competitive Landscape: Some of the major players of the market are Thermo Fisher Scientific Inc., QIAGEN N.V., Illumina, CareDx Inc., Immucor Inc., Bio-Rad Laboratories Inc., F. Hoffman-La Roche Ltd., Hologic Inc., Luminex, Biofortuna, Takara Bio, Omixon. Thermo Fisher Scientific provide different modalities for diagnostic imaging for transplant diagnostic surgeries including HLA typing. The company has emphasized on launching new products, collaborations and agreements for sustaining their leadership position. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global HLA typing market by technology, by product and service, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increased insistence for diagnostic products, increased private-public collaboration for extensive HLA research, rising prevalence of infectious diseases and soaring number of transplant processes are some of the crucial factors responsible for the growth of the market. HLA class I and II antigen identification is performed by the procedure of molecular diagnostics that is based on DNA. These novel innovations of the DNA are being utilised by the HLA typing that provide more accurate, vigorous results that rely on identifying the differences in HLA genes. Furthermore, advancements in technology, rise in the number of processes that involve stem cell transplantation, soft tissue transplantation and solid organ transplantation, bolstering support in R&D, escalating public and private funds are some of the other driving factors responsible for the HLA typing market growth. Additionally, the technological shift to gene-based HLA profiling from serological assays shall boost the proliferation of the market.
Market Segmentation:
By Technology • Molecular Assay Technologies • Non-Molecular Assay Technology By Products and Services • Reagents and Consumables • Instruments • Software and Services By Application • Diagnostic Applications • Research Applications By End User • Independent Reference Laboratories • Hospitals and Transplant Centers • Research Laboratories • Academic Institutes By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is fragmented into technology, products and services, application, end user and region. The technology segment is categorised into molecular assay technology and non-molecular assay technology. The molecular assay technology is divided into PCR-based molecular assays and sequencing based molecular assays. The molecular assay technology segment is predicted to hold the largest HLA typing market and this can be credited to the advantages provided by assays like high procedural efficacy, low turnaround time, real-time sample analysis and multi sample studying. The products and service segment is divided into reagents and consumables, instruments, software and services. The application segment is bifurcated into diagnostic applications and research applications. The end user segment is classified into hospitals and transplant centres, research laboratories, academic institutes and independent reference laboratories. The independent reference laboratories dominated the market, and this can be credited to the automation and rapid modernization of diagnostic labs, increased R&D activities that are outsourced by biotech and pharmaceutical companies.
Regional Analysis:
The North America region is expected to subjugate the market during the forecast period owing to advancements in the healthcare, increase in the number of organ transplantation surgeries performed and advancements in the transplant diagnostic technology.
Competitive Landscape:
Some of the major players of the market are Thermo Fisher Scientific Inc., QIAGEN N.V., Illumina, CareDx Inc., Immucor Inc., Bio-Rad Laboratories Inc., F. Hoffman-La Roche Ltd., Hologic Inc., Luminex, Biofortuna, Takara Bio, Omixon. Thermo Fisher Scientific provide different modalities for diagnostic imaging for transplant diagnostic surgeries including HLA typing. The company has emphasized on launching new products, collaborations and agreements for sustaining their leadership position.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global HLA typing market by technology, by product and service, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. HLA Typing Market, By Technology Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Molecular Assay Technologies 7.1.1 PCR-Based Molecular Assays 7.1.1.1 Real-Time PCR 7.1.1.2 Sequence-Specific Primer PCR 7.1.1.3 Sequence Specific Oligonucleotide PCR 7.1.1.4 Other PCR Molecular Assays 7.1.2 Sequencing based Molecular Assays 7.1.2.1 Sanger Sequencing 7.1.2.2 Next Generation Sequencing 7.1.2.3 Other Sequencing Based Molecular Assays 7.2 Non-Molecular Assay Technology 8. HLA Typing Market, By Product and Service Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Reagents and Consumables 8.2 Instruments 8.3 Software and Services 9. HLA Typing Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Diagnostic Applications 9.1.1 Antibody Screening 9.1.2 Chimerism Monitoring 9.1.3 Others 9.2 Research Applications 10. HLA Typing Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 10.1 Independent Reference Laboratories 10.2 Hospitals and Transplant Centers 10.3 Research Laboratories 10.4 Academic Institutes 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 11.2.1. U.S. 11.2.2. Canada 11.2.3. Mexico 11.2.4. Rest of North America 11.3 Market Size (USD Mn) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 12.3.1. Brazil 12.3.2. Venezuela 12.3.3. Argentina 12.3.4. Rest of Latin America 12.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5 Switzerland 13.2.6. Spain 13.2.7. Russia 13.2.8. Poland 13.2.9. Rest of Western Europe 13.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1 Introduction 14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 14.2.1 Japan 14.2.2 China 14.2.3 Singapore 14.2.4 Korea 14.2.5 India 14.2.6 Australia and New Zealand 14.2.7 ASEAN 14.2.8 Rest of Asia Pacific 14.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1 Introduction 15.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 15.2.1 UAE 15.2.2 South Africa 15.2.3 Egypt 15.2.4 Saudi Arabia 15.2.5 Rest of MEA 15.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 16.1 Thermo Fisher Scientific Inc. 16.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2 QIAGEN N.V. 16.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3 Illumina 16.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4 CareDx Inc. 16.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Immucor Inc. 16.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Bio-Rad Laboratories Inc. 16.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7 F. Hoffman-La Roche Ltd. 16.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8 Hologic Inc. 16.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9 Luminex 16.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10 Biofortuna 16.10.1. Company Overview (HQ, Business Segments, Employee Strength) 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11 Takara Bio 16.11.1. Company Overview (HQ, Business Segments, Employee Strength) 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12 Omixon 16.12.1. Company Overview (HQ, Business Segments, Employee Strength) 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16. Impact of COVID-19 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. Competitive Intelligence and Competitive Matrix 17.1 Competitive Intelligence 17.2 Competitive Matrix 18. Major Deals and Strategic Alliances Analysis 18.1 Joint ventures 18.2 Mergers and acquisitions 18.3 Licensing and partnerships 18.4 Technology Collaborations 18.5 Strategic Divestments 18.6 Market Entry Strategies 19. Relevant Case Studies and Latest News Updates 20. Research Sources and List of Primary Contacts of this Study 21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics